Chromax references:

References:

1- Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review.

Diabetes Technol Ther. 2006 Dec;8(6):677-87.

2- The ENVIRON Health Sciences Institute, 4350 North Fairfax Drive, Suite 300, Arlington, VA 22203, USA.

Determining the safety of chromium tripicolinate (chromax) for addition to foods as a nutrient supplement.

Food Chem Toxicol. 2004 Jun;42(6):1029-42.

3- Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA

Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.

Metabolism. 2010 May;59(5):755-62.

4- Ljubljana University Medical Centre, Ljubljana, Slovenia.

Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus.

Am Heart J. 2005 Apr;149(4):632-6.

5- Beltsville Human Nutrition Research Center, U.S. Department of Agriculture, Maryland 20705-2350, USA.

Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.

Diabetes. 1997 Nov;46(11):1786-91.

6- Mercy Health System-Northern Region Family Practice Residency, Toledo, Ohio 43624, USA.

Chromium picolinate supplementation for diabetes mellitus.

J Fam Pract. 1998 Jan;46(1):83-6.